(self.webpackChunk_N_E=self.webpackChunk_N_E||[]).push([[698],{3407:e=>{e.exports={recompPage:"page_recompPage__6BxE0",heroSection:"page_heroSection__opsS8",heroSplit:"page_heroSplit__Ztlnj",heroLeft:"page_heroLeft__8rL6Y",heroRight:"page_heroRight__11wYP",heroCenter:"page_heroCenter__6WBhk",heroIcon:"page_heroIcon__kkeIl",heroPhaseTitle:"page_heroPhaseTitle__n_M1D",heroPhaseSubtitle:"page_heroPhaseSubtitle__1Ffi8",heroList:"page_heroList__D4upm",heroTitle:"page_heroTitle__o3BtJ",heroSubtitle:"page_heroSubtitle__JWP20",pageNav:"page_pageNav__2RE9B",navButton:"page_navButton__Mbitm",sectionHeader:"page_sectionHeader__TzsUc",sectionLabel:"page_sectionLabel__cXWK0",sectionTitle:"page_sectionTitle__gMe_X",sectionDescription:"page_sectionDescription__TYe__",contentBlock:"page_contentBlock__1lb0u",subsectionTitle:"page_subsectionTitle__ElymG",problemSection:"page_problemSection__0FWAL",problemGrid:"page_problemGrid__gYKPu",problemCard:"page_problemCard__NuYD0",problemCardTitle:"page_problemCardTitle__rVEkZ",problemCardText:"page_problemCardText__j3kqe",traditionalDeficitDiagram:"page_traditionalDeficitDiagram__83Ori",reroutingDiagram:"page_reroutingDiagram__PeM2n",diagramTitle:"page_diagramTitle__czyXA",flowDiagram:"page_flowDiagram__RnXWd",flowBox:"page_flowBox__ZqKJY",flowLabel:"page_flowLabel__oM1_y",flowValue:"page_flowValue__s48e5",flowArrowDown:"page_flowArrowDown__Q6Hi6",flowNote:"page_flowNote__OCME9",flowSplit:"page_flowSplit__OpubD",flowSplitDual:"page_flowSplitDual__AKItg",flowPathway:"page_flowPathway__2QKCT",flowPathwayTitle:"page_flowPathwayTitle__1mUNA",flowResult:"page_flowResult__pJB_y",solutionSection:"page_solutionSection__qQoFT",strategyList:"page_strategyList__L6Z1w",strategyItem:"page_strategyItem__uf2z8",strategyNumber:"page_strategyNumber__8je_i",strategyContent:"page_strategyContent__WMW6F",strategyTitle:"page_strategyTitle__vzvXQ",strategyText:"page_strategyText__Pc6hf",validationSection:"page_validationSection__WrKph",fighterCard:"page_fighterCard__xvKK0",fighterQuote:"page_fighterQuote__bBuJY",quoteText:"page_quoteText__RRQGA",quoteAttribution:"page_quoteAttribution__CdSMu",quoteName:"page_quoteName__wA2EM",quoteSource:"page_quoteSource__J6JgF",fighterInsight:"page_fighterInsight__Aj6ee",insightTitle:"page_insightTitle__lOvPU",insightText:"page_insightText__RJxIi",pillarsSection:"page_pillarsSection__I8sjX",pillarBlock:"page_pillarBlock__74yB7",pillarTitle:"page_pillarTitle__V2tvE",pillarNumber:"page_pillarNumber__KmlIw",pillarSubtitle:"page_pillarSubtitle__x1oqQ",pillarDescription:"page_pillarDescription__i6QXL",pillarDiagram:"page_pillarDiagram__VB_l1",partitioningCards:"page_partitioningCards__Urp6V",anabolicGrid:"page_anabolicGrid__biddL",partitionCard:"page_partitionCard__TcwWu",anabolicCard:"page_anabolicCard__CoAUt",partitionTitle:"page_partitionTitle__ews5P",anabolicTitle:"page_anabolicTitle__lbgvy",partitionList:"page_partitionList__y0yza",anabolicLabel:"page_anabolicLabel__Cnzmu",anabolicText:"page_anabolicText__CgTG2",protocolsSection:"page_protocolsSection__peQZ2",protocolTier:"page_protocolTier__Trhfk",protocolHeader:"page_protocolHeader__1QhD9",protocolHeaderActive:"page_protocolHeaderActive__C7TdC",protocolHeaderContent:"page_protocolHeaderContent__dS_wq",protocolLabel:"page_protocolLabel__tapmi",protocolTitle:"page_protocolTitle__u_X4L",protocolGoal:"page_protocolGoal__cNtDm",protocolToggle:"page_protocolToggle__BrJcY",protocolToggleActive:"page_protocolToggleActive__TSRn0",protocolContent:"page_protocolContent__0O3pp",protocolIntro:"page_protocolIntro__ty2WQ",protocolTable:"page_protocolTable__YX4iT",tableHeader:"page_tableHeader___k9XE",tableHeaderCell:"page_tableHeaderCell__dPMdQ",tableRow:"page_tableRow__FXSuf",tableCell:"page_tableCell__Evw4q",protocolNotes:"page_protocolNotes__xH4ez",notesTitle:"page_notesTitle__uwPK7",notesList:"page_notesList__unoVd",notesText:"page_notesText__wq71z",outcomesCard:"page_outcomesCard__KItC8",outcomesTitle:"page_outcomesTitle__9Wj53",outcomesGrid:"page_outcomesGrid__gysGI",outcomeItem:"page_outcomeItem__Z7Q5H",outcomeValue:"page_outcomeValue__i0bCH",outcomeLabel:"page_outcomeLabel__1SAeb",outcomesNote:"page_outcomesNote__kNUr9",disclaimerFooter:"page_disclaimerFooter__qEy5r",disclaimerContent:"page_disclaimerContent__oVSUD",disclaimerTitle:"page_disclaimerTitle__E1wUX",disclaimerText:"page_disclaimerText__nd4uH",scrollTopButton:"page_scrollTopButton___eO8y"}},4946:(e,s,l)=>{"use strict";l.r(s),l.d(s,{default:()=>r});var a=l(5155),i=l(2115),t=l(3407),c=l.n(t);function r(){let[e,s]=(0,i.useState)(!1),[l,t]=(0,i.useState)(null);(0,i.useEffect)(()=>{let e=()=>{s(window.scrollY>400)};return window.addEventListener("scroll",e),()=>window.removeEventListener("scroll",e)},[]);let r=e=>{let s=document.getElementById(e);if(s){let e=s.getBoundingClientRect().top+window.scrollY-80;window.scrollTo({top:e,behavior:"smooth"})}};return(0,a.jsxs)("div",{className:c().recompPage,children:[(0,a.jsxs)("section",{className:c().heroSection,children:[(0,a.jsxs)("div",{className:c().heroSplit,children:[(0,a.jsxs)("div",{className:c().heroLeft,children:[(0,a.jsx)("div",{className:c().heroIcon,children:"☀"}),(0,a.jsx)("h3",{className:c().heroPhaseTitle,children:"AMPK Axis"}),(0,a.jsx)("p",{className:c().heroPhaseSubtitle,children:"Daytime"}),(0,a.jsxs)("ul",{className:c().heroList,children:[(0,a.jsx)("li",{children:"Fat oxidation bias"}),(0,a.jsx)("li",{children:"Mitochondrial stress signal"}),(0,a.jsx)("li",{children:"Cognitive throughput"}),(0,a.jsx)("li",{children:"Insulin sensitization"})]})]}),(0,a.jsxs)("div",{className:c().heroCenter,children:[(0,a.jsx)("h1",{className:c().heroTitle,children:"Dual-Axis Recomposition"}),(0,a.jsx)("p",{className:c().heroSubtitle,children:"Simultaneous fat loss and muscle preservation through metabolic re-routing"})]}),(0,a.jsxs)("div",{className:c().heroRight,children:[(0,a.jsx)("div",{className:c().heroIcon,children:"☾"}),(0,a.jsx)("h3",{className:c().heroPhaseTitle,children:"mTOR Axis"}),(0,a.jsx)("p",{className:c().heroPhaseSubtitle,children:"Nighttime"}),(0,a.jsxs)("ul",{className:c().heroList,children:[(0,a.jsx)("li",{children:"Protein synthesis bias"}),(0,a.jsx)("li",{children:"Tissue repair & growth"}),(0,a.jsx)("li",{children:"Growth hormone pulse"}),(0,a.jsx)("li",{children:"Parasympathetic dominance"})]})]})]}),(0,a.jsxs)("nav",{className:c().pageNav,children:[(0,a.jsx)("button",{onClick:()=>r("problem"),className:c().navButton,children:"The Problem"}),(0,a.jsx)("button",{onClick:()=>r("solution"),className:c().navButton,children:"The Solution"}),(0,a.jsx)("button",{onClick:()=>r("validation"),className:c().navButton,children:"Validation"}),(0,a.jsx)("button",{onClick:()=>r("pillars"),className:c().navButton,children:"Three Pillars"}),(0,a.jsx)("button",{onClick:()=>r("protocols"),className:c().navButton,children:"Protocols"})]})]}),(0,a.jsxs)("section",{id:"problem",className:c().problemSection,children:[(0,a.jsxs)("div",{className:c().sectionHeader,children:[(0,a.jsx)("span",{className:c().sectionLabel,children:"THE PROBLEM"}),(0,a.jsx)("h2",{className:c().sectionTitle,children:"CICO: A Thermodynamic Tautology"}),(0,a.jsx)("p",{className:c().sectionDescription,children:'"Calories in, calories out" is thermodynamically true and practically useless—like telling someone to "just be happy"'})]}),(0,a.jsxs)("div",{className:c().contentBlock,children:[(0,a.jsx)("h3",{className:c().subsectionTitle,children:"Why CICO Fails as a Coaching Framework"}),(0,a.jsxs)("div",{className:c().problemGrid,children:[(0,a.jsxs)("div",{className:c().problemCard,children:[(0,a.jsx)("h4",{className:c().problemCardTitle,children:"Unknowable Output"}),(0,a.jsxs)("p",{className:c().problemCardText,children:[(0,a.jsx)("strong",{children:"Resting Metabolic Rate"})," fluctuates with thyroid output, inflammatory load, circadian alignment, and mitochondrial efficiency. Sleep-deprived athletes see RMR drop despite identical calorie intake."]})]}),(0,a.jsxs)("div",{className:c().problemCard,children:[(0,a.jsx)("h4",{className:c().problemCardTitle,children:"Variable Expenditure"}),(0,a.jsxs)("p",{className:c().problemCardText,children:[(0,a.jsx)("strong",{children:"NEAT"})," (non-exercise activity thermogenesis) swings hundreds of calories daily with stress, stimulants, travel, or subconscious fidgeting. Impossible to track in real time."]})]}),(0,a.jsxs)("div",{className:c().problemCard,children:[(0,a.jsx)("h4",{className:c().problemCardTitle,children:"Substrate Selection"}),(0,a.jsxs)("p",{className:c().problemCardText,children:[(0,a.jsx)("strong",{children:"Hormonal landscape"})," (insulin, glucagon, cortisol) decides which tissues are sacrificed. Chronic hyperinsulinemia blocks lipolysis; low insulin sensitivity pulls amino acids from muscle."]})]}),(0,a.jsxs)("div",{className:c().problemCard,children:[(0,a.jsx)("h4",{className:c().problemCardTitle,children:"Corrupted Input"}),(0,a.jsxs)("p",{className:c().problemCardText,children:[(0,a.jsx)("strong",{children:"FDA nutrition labels"}),' are based on institutionally corrupted data. Even "calories in" is a best-guess estimate from compromised sources.']})]})]}),(0,a.jsxs)("div",{className:c().traditionalDeficitDiagram,children:[(0,a.jsx)("h4",{className:c().diagramTitle,children:"Traditional Caloric Deficit Outcome"}),(0,a.jsxs)("div",{className:c().flowDiagram,children:[(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Energy Deficit"}),(0,a.jsx)("div",{className:c().flowValue,children:"-500 kcal/day"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowSplit,children:[(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Fat Loss"}),(0,a.jsx)("div",{className:c().flowValue,children:"60%"})]}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Muscle Loss"}),(0,a.jsx)("div",{className:c().flowValue,children:"40%"})]})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Result"}),(0,a.jsx)("div",{className:c().flowValue,children:"Weight down, strength down, metabolism slower"})]})]})]})]})]}),(0,a.jsxs)("section",{id:"solution",className:c().solutionSection,children:[(0,a.jsxs)("div",{className:c().sectionHeader,children:[(0,a.jsx)("span",{className:c().sectionLabel,children:"THE SOLUTION"}),(0,a.jsx)("h2",{className:c().sectionTitle,children:"Physics Remains. Physiology Chooses."}),(0,a.jsx)("p",{className:c().sectionDescription,children:"Keep the deficit. Re-route the payment method."})]}),(0,a.jsxs)("div",{className:c().contentBlock,children:[(0,a.jsx)("h3",{className:c().subsectionTitle,children:"The Dual-Axis Strategy"}),(0,a.jsxs)("div",{className:c().strategyList,children:[(0,a.jsxs)("div",{className:c().strategyItem,children:[(0,a.jsx)("div",{className:c().strategyNumber,children:"01"}),(0,a.jsxs)("div",{className:c().strategyContent,children:[(0,a.jsx)("h4",{className:c().strategyTitle,children:"Create Controllable Expenditure"}),(0,a.jsx)("p",{className:c().strategyText,children:"Retatrutide's GLP-1/GIP/glucagon agonism increases energy output and appetite suppression"})]})]}),(0,a.jsxs)("div",{className:c().strategyItem,children:[(0,a.jsx)("div",{className:c().strategyNumber,children:"02"}),(0,a.jsxs)("div",{className:c().strategyContent,children:[(0,a.jsx)("h4",{className:c().strategyTitle,children:"Provide Alternative Fuel"}),(0,a.jsx)("p",{className:c().strategyText,children:"Morning AMPK stack (AOD-9604, L-Carnitine, MOTS-c) floods mitochondria with fatty acids so fat becomes the preferred substrate"})]})]}),(0,a.jsxs)("div",{className:c().strategyItem,children:[(0,a.jsx)("div",{className:c().strategyNumber,children:"03"}),(0,a.jsxs)("div",{className:c().strategyContent,children:[(0,a.jsx)("h4",{className:c().strategyTitle,children:"Make Muscle Metabolically Expensive"}),(0,a.jsx)("p",{className:c().strategyText,children:"Evening anabolic axis (Tesamorelin \xb1 Ipamorelin) plus consistent protein intake (1.6–2.2 g/kg) signals the body to protect lean tissue"})]})]}),(0,a.jsxs)("div",{className:c().strategyItem,children:[(0,a.jsx)("div",{className:c().strategyNumber,children:"04"}),(0,a.jsxs)("div",{className:c().strategyContent,children:[(0,a.jsx)("h4",{className:c().strategyTitle,children:"Optimize Insulin Sensitivity"}),(0,a.jsx)("p",{className:c().strategyText,children:"Resistance training, Zone-2 cardio, circadian alignment, and MOTS-c ensure glucose uptake stays high in muscle, low in visceral fat"})]})]})]}),(0,a.jsxs)("div",{className:c().reroutingDiagram,children:[(0,a.jsx)("h4",{className:c().diagramTitle,children:"Metabolic Re-routing Architecture"}),(0,a.jsxs)("div",{className:c().flowDiagram,children:[(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Energy Deficit"}),(0,a.jsx)("div",{className:c().flowValue,children:"Retatrutide"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsx)("div",{className:c().flowNote,children:"Would normally cause both fat AND muscle loss"}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowSplitDual,children:[(0,a.jsxs)("div",{className:c().flowPathway,children:[(0,a.jsx)("div",{className:c().flowPathwayTitle,children:"Fat Mobilization Channel"}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"AOD-9604"}),(0,a.jsx)("div",{className:c().flowValue,children:"Lipolysis ↑"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"L-Carnitine"}),(0,a.jsx)("div",{className:c().flowValue,children:"Fat Transport"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"MOTS-c"}),(0,a.jsx)("div",{className:c().flowValue,children:"AMPK Priming"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"SS-31 + NAD+"}),(0,a.jsx)("div",{className:c().flowValue,children:"Mitochondrial Output"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsx)("div",{className:c().flowResult,children:"Abundant Fatty Acids"})]}),(0,a.jsxs)("div",{className:c().flowPathway,children:[(0,a.jsx)("div",{className:c().flowPathwayTitle,children:"Muscle Preservation Blocks"}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Tesamorelin"}),(0,a.jsx)("div",{className:c().flowValue,children:"GH Pulses"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Protein Intake"}),(0,a.jsx)("div",{className:c().flowValue,children:"1.6–2.2 g/kg"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Resistance Training"}),(0,a.jsx)("div",{className:c().flowValue,children:"Stimulus"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"BPC-157 + TB-500"}),(0,a.jsx)("div",{className:c().flowValue,children:"Tissue Repair"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsx)("div",{className:c().flowResult,children:"Muscle Protected"})]})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Outcome"}),(0,a.jsx)("div",{className:c().flowValue,children:"Selective fat loss, lean mass preserved or increased"})]})]})]})]})]}),(0,a.jsxs)("section",{id:"validation",className:c().validationSection,children:[(0,a.jsxs)("div",{className:c().sectionHeader,children:[(0,a.jsx)("span",{className:c().sectionLabel,children:"VALIDATION"}),(0,a.jsx)("h2",{className:c().sectionTitle,children:"The Fighter Proof"}),(0,a.jsx)("p",{className:c().sectionDescription,children:"Precision metabolic engineering isn't theoretical—fighters prove it every fight week"})]}),(0,a.jsxs)("div",{className:c().fighterCard,children:[(0,a.jsxs)("div",{className:c().fighterQuote,children:[(0,a.jsx)("p",{className:c().quoteText,children:'"Fighters routinely drop 10–15 lb in days through glycogen depletion, gut-emptying, electrolyte shifts, and water manipulation—without proportional loss in functional muscle. Within 24 hours they rehydrate, reload, and perform at elite levels."'}),(0,a.jsxs)("div",{className:c().quoteAttribution,children:[(0,a.jsx)("span",{className:c().quoteName,children:"George Lockhart"}),(0,a.jsx)("span",{className:c().quoteSource,children:"MMA Nutritionist, JRE MMA Show #44"})]})]}),(0,a.jsxs)("div",{className:c().fighterInsight,children:[(0,a.jsx)("h4",{className:c().insightTitle,children:"The Critical Insight"}),(0,a.jsxs)("p",{className:c().insightText,children:["The energy ledger balanced. The ",(0,a.jsx)("em",{children:"path"})," energy took was engineered."]}),(0,a.jsx)("p",{className:c().insightText,children:"Dual-Axis Recomposition applies this same precision year-round: create the deficit, control the substrate selection, protect the lean tissue."})]})]})]}),(0,a.jsxs)("section",{id:"pillars",className:c().pillarsSection,children:[(0,a.jsxs)("div",{className:c().sectionHeader,children:[(0,a.jsx)("span",{className:c().sectionLabel,children:"MECHANISTIC FOUNDATIONS"}),(0,a.jsx)("h2",{className:c().sectionTitle,children:"Three Pillars"}),(0,a.jsx)("p",{className:c().sectionDescription,children:"Foundation, partitioning, and protection working in concert"})]}),(0,a.jsxs)("div",{className:c().pillarBlock,children:[(0,a.jsxs)("h3",{className:c().pillarTitle,children:[(0,a.jsx)("span",{className:c().pillarNumber,children:"I"}),"Mitochondrial Foundation"]}),(0,a.jsx)("p",{className:c().pillarSubtitle,children:"Hardware, software, and fuel"}),(0,a.jsxs)("div",{className:c().pillarDiagram,children:[(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"SS-31 (Elamipretide)"}),(0,a.jsx)("div",{className:c().flowValue,children:"Stabilizes cardiolipin"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"Prevents Electron Leak"}),(0,a.jsx)("div",{className:c().flowValue,children:"Efficient ETC"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"NAD+ Cofactors"}),(0,a.jsx)("div",{className:c().flowValue,children:"Redox currency"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowBox,children:[(0,a.jsx)("div",{className:c().flowLabel,children:"MOTS-c Signaling"}),(0,a.jsx)("div",{className:c().flowValue,children:"AMPK/FOXO optimization"})]}),(0,a.jsx)("div",{className:c().flowArrowDown}),(0,a.jsxs)("div",{className:c().flowSplit,children:[(0,a.jsx)("div",{className:c().flowResult,children:"Training Capacity ↑"}),(0,a.jsx)("div",{className:c().flowResult,children:"Recovery Debt ↓"})]})]}),(0,a.jsx)("p",{className:c().pillarDescription,children:"Higher sustained work output, fewer post-exertional crashes, and a metabolic environment where lipolysis and protein synthesis can both occur without bottlenecks."})]}),(0,a.jsxs)("div",{className:c().pillarBlock,children:[(0,a.jsxs)("h3",{className:c().pillarTitle,children:[(0,a.jsx)("span",{className:c().pillarNumber,children:"II"}),"Metabolic Partitioning"]}),(0,a.jsx)("p",{className:c().pillarSubtitle,children:"Re-routing Retatrutide's catabolic pressure"}),(0,a.jsx)("p",{className:c().pillarDescription,children:"Retatrutide activates GLP-1 (appetite control), GIP (insulinotropic), and glucagon (energy expenditure and lipolysis). Alone, glucagon can strip lean tissue. The stack redirects that pressure toward fat while protecting muscle."}),(0,a.jsxs)("div",{className:c().partitioningCards,children:[(0,a.jsxs)("div",{className:c().partitionCard,children:[(0,a.jsx)("h4",{className:c().partitionTitle,children:"Fat Mobilization"}),(0,a.jsxs)("ul",{className:c().partitionList,children:[(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"AOD-9604"})," — Lipolysis via β3 receptors"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"L-Carnitine"})," — Fatty acid transport"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"MOTS-c"})," — AMPK priming"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"Zone-2 Training"})," — Fat oxidation bias"]})]})]}),(0,a.jsxs)("div",{className:c().partitionCard,children:[(0,a.jsx)("h4",{className:c().partitionTitle,children:"Muscle Protection"}),(0,a.jsxs)("ul",{className:c().partitionList,children:[(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"Tesamorelin"})," — GH pulses"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"Protein"})," — 1.6–2.2 g/kg daily"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"Resistance Training"})," — Stimulus"]}),(0,a.jsxs)("li",{children:[(0,a.jsx)("strong",{children:"BPC-157 + TB-500"})," — Tissue repair"]})]})]})]})]}),(0,a.jsxs)("div",{className:c().pillarBlock,children:[(0,a.jsxs)("h3",{className:c().pillarTitle,children:[(0,a.jsx)("span",{className:c().pillarNumber,children:"III"}),"Anabolic Counterweight"]}),(0,a.jsx)("p",{className:c().pillarSubtitle,children:"Protecting and building lean tissue under deficit"}),(0,a.jsxs)("div",{className:c().anabolicGrid,children:[(0,a.jsxs)("div",{className:c().anabolicCard,children:[(0,a.jsx)("span",{className:c().anabolicLabel,children:"NON-NEGOTIABLE"}),(0,a.jsx)("h4",{className:c().anabolicTitle,children:"Protein Intake"}),(0,a.jsx)("p",{className:c().anabolicText,children:"1.6–2.2 g/kg bodyweight daily, distributed evenly (20–40 g per feeding). Protein is the structural signal that tells the body you can afford to rebuild."})]}),(0,a.jsxs)("div",{className:c().anabolicCard,children:[(0,a.jsx)("span",{className:c().anabolicLabel,children:"GH PULSE"}),(0,a.jsx)("h4",{className:c().anabolicTitle,children:"Tesamorelin"}),(0,a.jsx)("p",{className:c().anabolicText,children:"1–2 mg nightly strengthens GH pulses, preferentially reducing visceral fat and supporting collagen synthesis."})]}),(0,a.jsxs)("div",{className:c().anabolicCard,children:[(0,a.jsx)("span",{className:c().anabolicLabel,children:"TISSUE REPAIR"}),(0,a.jsx)("h4",{className:c().anabolicTitle,children:"Repair Peptides"}),(0,a.jsx)("p",{className:c().anabolicText,children:"BPC-157, TB-500, GHK-Cu, and KPV channel anabolic signaling into resilient connective tissue."})]})]})]})]}),(0,a.jsxs)("section",{id:"protocols",className:c().protocolsSection,children:[(0,a.jsxs)("div",{className:c().sectionHeader,children:[(0,a.jsx)("span",{className:c().sectionLabel,children:"IMPLEMENTATION"}),(0,a.jsx)("h2",{className:c().sectionTitle,children:"Protocol Tiers"}),(0,a.jsx)("p",{className:c().sectionDescription,children:"Beginner, intermediate, and advanced stacks with progressive complexity"})]}),(0,a.jsxs)("div",{className:c().protocolTier,children:[(0,a.jsxs)("button",{className:"".concat(c().protocolHeader," ").concat("beginner"===l?c().protocolHeaderActive:""),onClick:()=>t("beginner"===l?null:"beginner"),children:[(0,a.jsxs)("div",{className:c().protocolHeaderContent,children:[(0,a.jsx)("span",{className:c().protocolLabel,children:"TIER 1"}),(0,a.jsx)("h3",{className:c().protocolTitle,children:"Beginner Stack"}),(0,a.jsx)("p",{className:c().protocolGoal,children:"Core dual-axis framework"})]}),(0,a.jsx)("div",{className:"".concat(c().protocolToggle," ").concat("beginner"===l?c().protocolToggleActive:""),children:"beginner"===l?"−":"+"})]}),"beginner"===l&&(0,a.jsx)("div",{className:c().protocolContent,children:(0,a.jsxs)("div",{className:c().protocolTable,children:[(0,a.jsxs)("div",{className:c().tableHeader,children:[(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Time"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Intervention"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Dose"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Notes"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"AM Fasted"}),(0,a.jsx)("div",{className:c().tableCell,children:"L-Carnitine"}),(0,a.jsx)("div",{className:c().tableCell,children:"200–500 mg IM/SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"≥16 h fast ideal (12 h minimum)"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"AM Fasted"}),(0,a.jsx)("div",{className:c().tableCell,children:"Retatrutide"}),(0,a.jsx)("div",{className:c().tableCell,children:"0.5 mg weekly"}),(0,a.jsx)("div",{className:c().tableCell,children:"Titrate in 0.25 mg steps every ≥4 wk"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Mid-Day"}),(0,a.jsx)("div",{className:c().tableCell,children:"NAD+"}),(0,a.jsx)("div",{className:c().tableCell,children:"100–200 mg IM"}),(0,a.jsx)("div",{className:c().tableCell,children:"3\xd7/wk, aligns with circadian NAD+ trough"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Evening"}),(0,a.jsx)("div",{className:c().tableCell,children:"Tesamorelin"}),(0,a.jsx)("div",{className:c().tableCell,children:"1–2 mg SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"60–90 min after dinner"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Daily"}),(0,a.jsx)("div",{className:c().tableCell,children:"Protein"}),(0,a.jsx)("div",{className:c().tableCell,children:"1.6–2.2 g/kg"}),(0,a.jsx)("div",{className:c().tableCell,children:"Spread over 4–5 meals (≥20 g per meal)"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Training"}),(0,a.jsx)("div",{className:c().tableCell,children:"Resistance + Zone-2"}),(0,a.jsx)("div",{className:c().tableCell,children:"3–4 lifts, 2–3 cardio"}),(0,a.jsx)("div",{className:c().tableCell,children:"Fasted Zone-2 aligns with AMPK axis"})]})]})})]}),(0,a.jsxs)("div",{className:c().protocolTier,children:[(0,a.jsxs)("button",{className:"".concat(c().protocolHeader," ").concat("intermediate"===l?c().protocolHeaderActive:""),onClick:()=>t("intermediate"===l?null:"intermediate"),children:[(0,a.jsxs)("div",{className:c().protocolHeaderContent,children:[(0,a.jsx)("span",{className:c().protocolLabel,children:"TIER 2"}),(0,a.jsx)("h3",{className:c().protocolTitle,children:"Intermediate Stack"}),(0,a.jsx)("p",{className:c().protocolGoal,children:"Mitochondrial and lipolytic enhancements"})]}),(0,a.jsx)("div",{className:"".concat(c().protocolToggle," ").concat("intermediate"===l?c().protocolToggleActive:""),children:"intermediate"===l?"−":"+"})]}),"intermediate"===l&&(0,a.jsxs)("div",{className:c().protocolContent,children:[(0,a.jsx)("p",{className:c().protocolIntro,children:"Adds SS-31, MOTS-c, AOD-9604; optional Ipamorelin"}),(0,a.jsxs)("div",{className:c().protocolTable,children:[(0,a.jsxs)("div",{className:c().tableHeader,children:[(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Time"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Intervention"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Dose"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Notes"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"AM Fasted"}),(0,a.jsx)("div",{className:c().tableCell,children:"AOD-9604"}),(0,a.jsx)("div",{className:c().tableCell,children:"250–500 \xb5g SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"Daily; GH 177-191 fragment for lipolysis"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"AM Pre-Training"}),(0,a.jsx)("div",{className:c().tableCell,children:"MOTS-c"}),(0,a.jsx)("div",{className:c().tableCell,children:"5–10 mg SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"2–3\xd7/wk; enhances glucose uptake & fat oxidation"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"AM Pre-Training"}),(0,a.jsx)("div",{className:c().tableCell,children:"SS-31"}),(0,a.jsx)("div",{className:c().tableCell,children:"5–10 mg SC/IM"}),(0,a.jsx)("div",{className:c().tableCell,children:"Daily weeks 1–3, then 3\xd7/wk maintenance"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Evening"}),(0,a.jsx)("div",{className:c().tableCell,children:"Ipamorelin (optional)"}),(0,a.jsx)("div",{className:c().tableCell,children:"200–300 \xb5g SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"With Tesamorelin"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Weekly"}),(0,a.jsx)("div",{className:c().tableCell,children:"Retatrutide"}),(0,a.jsx)("div",{className:c().tableCell,children:"Titrate → 3–5 mg"}),(0,a.jsx)("div",{className:c().tableCell,children:"As tolerated"})]})]}),(0,a.jsxs)("div",{className:c().protocolNotes,children:[(0,a.jsx)("h4",{className:c().notesTitle,children:"Cycling Guidance"}),(0,a.jsxs)("ul",{className:c().notesList,children:[(0,a.jsx)("li",{children:"MOTS-c: 4–6 weeks on → 2–4 weeks off"}),(0,a.jsx)("li",{children:"SS-31: 4–8 week intensive → 3\xd7/wk maintenance"}),(0,a.jsx)("li",{children:"Retatrutide: maintain lowest effective dose; reassess quarterly"})]})]})]})]}),(0,a.jsxs)("div",{className:c().protocolTier,children:[(0,a.jsxs)("button",{className:"".concat(c().protocolHeader," ").concat("advanced"===l?c().protocolHeaderActive:""),onClick:()=>t("advanced"===l?null:"advanced"),children:[(0,a.jsxs)("div",{className:c().protocolHeaderContent,children:[(0,a.jsx)("span",{className:c().protocolLabel,children:"TIER 3"}),(0,a.jsx)("h3",{className:c().protocolTitle,children:"Advanced Stack"}),(0,a.jsx)("p",{className:c().protocolGoal,children:"Circadian and neuro-axis optimization"})]}),(0,a.jsx)("div",{className:"".concat(c().protocolToggle," ").concat("advanced"===l?c().protocolToggleActive:""),children:"advanced"===l?"−":"+"})]}),"advanced"===l&&(0,a.jsxs)("div",{className:c().protocolContent,children:[(0,a.jsx)("p",{className:c().protocolIntro,children:"Layers VIP, DSIP, Semax/Selank for circadian and autonomic optimization"}),(0,a.jsxs)("div",{className:c().protocolTable,children:[(0,a.jsxs)("div",{className:c().tableHeader,children:[(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Time"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Intervention"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Dose"}),(0,a.jsx)("div",{className:c().tableHeaderCell,children:"Notes"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"6:00 AM"}),(0,a.jsx)("div",{className:c().tableCell,children:"VIP"}),(0,a.jsx)("div",{className:c().tableCell,children:"25–100 \xb5g SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"Aligns with cortisol awakening response"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"6:15 AM"}),(0,a.jsx)("div",{className:c().tableCell,children:"Semax + Selank"}),(0,a.jsx)("div",{className:c().tableCell,children:"250–500 \xb5g each SC/IN"}),(0,a.jsx)("div",{className:c().tableCell,children:"BDNF boost + cortisol modulation"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"Mid-Day"}),(0,a.jsx)("div",{className:c().tableCell,children:"NAD+"}),(0,a.jsx)("div",{className:c().tableCell,children:"200–300 mg IM"}),(0,a.jsx)("div",{className:c().tableCell,children:"3\xd7/wk or IV weekly"})]}),(0,a.jsxs)("div",{className:c().tableRow,children:[(0,a.jsx)("div",{className:c().tableCell,children:"90–120 min pre-sleep"}),(0,a.jsx)("div",{className:c().tableCell,children:"DSIP"}),(0,a.jsx)("div",{className:c().tableCell,children:"100–300 \xb5g SC"}),(0,a.jsx)("div",{className:c().tableCell,children:"Modulates slow-wave architecture"})]})]}),(0,a.jsxs)("div",{className:c().protocolNotes,children:[(0,a.jsx)("h4",{className:c().notesTitle,children:"Cortisol Steering"}),(0,a.jsx)("p",{className:c().notesText,children:"Dual-Axis Recomposition depends on natural AM cortisol rise and exercise-induced pulses to mobilize fat. The circadian layer targets dysregulated peaks (travel, chronic stress) rather than suppressing all cortisol output."})]})]})]}),(0,a.jsxs)("div",{className:c().outcomesCard,children:[(0,a.jsx)("h3",{className:c().outcomesTitle,children:"Expected Outcomes"}),(0,a.jsxs)("div",{className:c().outcomesGrid,children:[(0,a.jsxs)("div",{className:c().outcomeItem,children:[(0,a.jsx)("div",{className:c().outcomeValue,children:"3–6 kg"}),(0,a.jsx)("div",{className:c().outcomeLabel,children:"Scale weight reduction"})]}),(0,a.jsxs)("div",{className:c().outcomeItem,children:[(0,a.jsx)("div",{className:c().outcomeValue,children:"<0.5 kg"}),(0,a.jsx)("div",{className:c().outcomeLabel,children:"Lean mass loss (DEXA/InBody)"})]}),(0,a.jsxs)("div",{className:c().outcomeItem,children:[(0,a.jsx)("div",{className:c().outcomeValue,children:"15–30%"}),(0,a.jsx)("div",{className:c().outcomeLabel,children:"Visceral fat area reduction"})]}),(0,a.jsxs)("div",{className:c().outcomeItem,children:[(0,a.jsx)("div",{className:c().outcomeValue,children:"→ or ↑"}),(0,a.jsx)("div",{className:c().outcomeLabel,children:"Strength markers (big-three lifts)"})]})]}),(0,a.jsx)("p",{className:c().outcomesNote,children:"8–12 week protocol runs. Internal data from trained individuals under medical supervision."})]})]}),(0,a.jsx)("footer",{className:c().disclaimerFooter,children:(0,a.jsxs)("div",{className:c().disclaimerContent,children:[(0,a.jsx)("h4",{className:c().disclaimerTitle,children:"Research Information Only"}),(0,a.jsx)("p",{className:c().disclaimerText,children:"This protocol is presented for educational and research purposes. It is intended for otherwise healthy, training-active adults working with qualified medical supervision. This information does not replace individualized medical advice."}),(0,a.jsxs)("p",{className:c().disclaimerText,children:[(0,a.jsx)("strong",{children:"Contraindications:"})," Active malignancy, pregnancy, unmanaged gallbladder disease, severe GI disorders. Retatrutide is investigational (Phase 3), not FDA-approved. Tesamorelin is FDA-approved for HIV-associated lipodystrophy; other uses are off-label. Other peptides are compounded; monitor supplier quality."]}),(0,a.jsxs)("p",{className:c().disclaimerText,children:[(0,a.jsx)("strong",{children:"Regulatory note:"})," Retatrutide is prohibited in tested sport. Anyone with significant medical conditions, recent surgery, or medication regimens should consult their clinician before initiating."]})]})}),e&&(0,a.jsx)("button",{className:c().scrollTopButton,onClick:()=>{window.scrollTo({top:0,behavior:"smooth"})},"aria-label":"Scroll to top",children:"↑"})]})}},6840:(e,s,l)=>{Promise.resolve().then(l.bind(l,4946))}},e=>{e.O(0,[620,441,255,358],()=>e(e.s=6840)),_N_E=e.O()}]);